Exchange: NASDAQ·Updated 12:00 AM EST

TXSS News

News
all
press releases
Taysha also announced that it has finalized alignment with the FDA on the protocol for the trial intended to support its application for approval of TSHA-102.
Stocktwits

Advertisement|Remove ads.